Amicus Therapeutics, Inc. logo

Amicus Therapeutics, Inc. (FOLD)

Delisted
27 Apr 2026
NASDAQ (NMS) NASDAQ (NMS)
$
14. 49
0
0%
$
4.55B Market Cap
- P/E Ratio
- Div Yield
5.29M Volume
-0.45 Eps
$ 14.49
Previous Close
Day Range
14.49 14.49
Year Range
5.51 14.5
Want to track FOLD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Amicus Therapeutics, Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
RW
Riley Wancket HANTZ FINANCIAL SERVICES Inc.
132 $2 $2 - -
DB
David Barlow Glazer Capital LLC
12.72M $183.62M $183.97M $352,780.76 0.19%
MB
Mitchel Bialek Css LLC/IL
33,500 $484.41 $484.41 - -
KM
Kristin Mariani Janus Henderson Group PLC
137,571 $1.62M $1.99M $368,222.48 22.72%
RAS
Robert A. Saperstein Guggenheim Capital LLC
84,973 $860.39 $1,228.71 $368.32 42.81%
KJD
Kathryn J. Daniels Canada Pension Plan Investment Board
273,227 $2.26M $3.95M $1.69M 74.82%
AKW
Adriel Kuan Wui Loh OVERSEA-CHINESE BANKING Corp Ltd
28,386 $347,000 $347,000 - -
MC
Mike Clark Cassady Schiller Wealth Management LLC
44 $0.41 $0.41 - -
Tricia Peterson
Tricia Peterson Mesirow Institutional Investment Management Inc.
89,382 $975.05 $841.98 -$133.07 -13.65%
MC
Megan Claucherty Kodai Capital Management LP
605,110 $4.94M $4.94M - -
Angela Mari
Angela Mari Abich Financial Wealth Management LLC
10,779 $84,939 $84,939 - -
VT
Vincent Tortorella Point72 (DIFC) Ltd
34,876 $269,748.33 $274,822 $5,073.67 1.88%
Charles Hillier
Charles Hillier Cibra Capital Ltd.
1.69M $24.36M $24.4M $46,376 0.19%